AMY ULLAN: Open Payments
NPI 1356516314 · SALEM, OR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,586 in 66 payments from 17 companies in 2025. Trend: 2023 $1,549 · 2024 $1,927 · 2025 $1,586
Food & beverage: $1,486Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $473 |
| Janssen Biotech, Inc. | 7 | $218 |
| GENZYME CORPORATION | 6 | $158 |
| UCB, Inc. | 4 | $122 |
| Incyte Corporation | 4 | $90 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Amgen Inc. | 3 | $70 |
| Lilly USA, LLC | 3 | $68 |
| PFIZER INC. | 3 | $58 |
| Galderma Laboratories, L.P. | 3 | $57 |
Products named: SKYRIZI, TREMFYA, RINVOQ, DUPIXENT, Bimzelx, OPZELURA, Otezla, TALTZ.
Industry payments across OR — which companies pay providers there.
